Egle Identifies First Novel Regulatory T-cell Targets Under its Collaboration with Takeda

November 27, 2020 Auto Bot Agreement, Biotech, First, Novel, regulatory, Research, T-cell, Takeda, Therapeutics 0

Shots:

  • Egle has achieved the first milestone in its research agreement with Takeda, signed in June’2020. Egle will validate novel tumor-infiltrating regulatory T-cell targets while Takeda will develop the potential therapies
  • Egle has leveraged its unique bioinformatic & translational capabilities to identify targets
  • Following the achievement of the target identification, Egle will receive an R&D milestone payment & equity funding from Takeda

Click here ­to­ read full press release/ article | Ref: Businesswire| Image: Businesswire

The post Egle Identifies First Novel Regulatory T-cell Targets Under its Collaboration with Takeda first appeared on PharmaShots.